Joint Development Marketing Dispute. In a dispute between two pharmaceutical companies that had jointly developed a drug, Cornerstone Research worked with an expert who assessed the business incentives of the company responsible for marketing the drug. This company was alleged to have developed an inappropriate marketing plan because it had other drugs in the therapeutic space that could potentially lose sales to the new drug

What aspect of the dispute was the focus of the assessment conducted by the expert?